Month: July 2020

(Bloomberg) — The euro opened the week on the backfoot after negotiations over the European Union’s shared debt recovery plan continued to drag on.EU leaders have yet to agree terms on a deal that would offer 700 billion euros ($800 billion) to countries most impacted by the coronavirus, after talks ran into a third day. Though expectations for an agreement over the weekend were fairly low, the delay keeps open the prospect of the plan being watered down.The euro fell as much as 0.2% against the dollar to $1.1408 in early Sydney trade on Monday. The greenback also strengthened against …read more […]

Journal Editorial Report: The week’s best and worst from Kim Strassel, Holman Jenkins and Dan Henninger. Images: AFP/Getty Images Composite: Mark Kelly …read more […]

Biotech stocks advanced in the week ended July 17 thanks to positive broader market sentiment, encouraging news flow on the COVID-19 front and fairly positive results reported by pharma giant Johnson & Johnson (NYSE: JNJ).Equillium Inc (NASDAQ: EQ) was among the biggest gainers of the week after a drug that it licensed from Biocon was granted emergency use authorization in India for treating cytokine release syndrome in COVID-19 patients with moderate to severe acute respiratory distress syndrome.Moderna Inc (NASDAQ: MRNA) advanced in all five sessions of the week, with detailed interim Phase 1 data publication, positive sell-side commentary and news …read more […]

Journal Editorial Report: Paul Gigot interviews Michael Pillsbury. Image: Anthony Kwan/Getty Images …read more […]

Journal Editorial Report: The tensions over reopening in the fall. Image: Octavio Jones/Getty Images …read more […]

Shares of Nikola Corporation (NASDAQ: NKLA) traded sharply lower Friday afternoon as the SEC released news of Nikola offering 23,890,000 common shares.The company’s shares were already down almost 20% on the month before news of the offering hit. > “This prospectus relates to the issuance by us of up to an aggregate of up to 23,890,000 shares of our common stock, $0.0001 par value per share (“Common Stock”), which consists of (i) up to 890,000 shares of Common Stock that are issuable upon the exercise of 890,000 warrants (the “Private Warrants”) originally issued in a private placement in connection with …read more […]

Welcome to another edition of my weekly review of dividend increases. I follow this process in order to monitor existing dividend holdings. It is helpful to see if my investments continue growing their dividends, and if my original investment thesis is working. I also find this process helpful, in order to identify companies for further research. WBA Riased […] …read more […]

The gold price remains above $1,800 an ounce, but where it will go next depends on what type of economic recovery we see. Many are expecting a V-shaped recovery. However, the resurgence in coronavirus cases in the U.S. suggests we could see a U-shaped or W-shaped economic recovery, which would impact gold prices. Gold outperformed while equities […] …read more […]

The current earnings reports that begin rolling out this week will be among the most important since the financial crisis, if not even before that. To explain why, let us start with some background data. Exhibit 1 plots the three major stock market indexes from the start of the year through the close on July 10, 2020. […] …read more […]

Tesla stock skyrocketed 14% on Monday on speculations that it will be added to the S&P 500. However, the shares plunged into the red briefly in the afternoon in a wild day of trading before climbing back into the green before the market closed. Tesla stock approaches $1,800 on S&P 500 speculations Tesla stock (NASDAQ:TSLA) soared to […] …read more […]

Vaccine manufacturers testify before Congress, earnings bonanza: What to know in the week ahead …read more […]

A Joe Biden presidency wouldn’t just be a win for the Democrats, it would be a win for managed care organizations (MCOs). Back in March, the former Vice President’s strong showing on Super Tuesday fueled a rally from large health insurance stocks. Why? It came down to Senator Bernie Sanders’ proposed Medicare for All program that would largely do away with the need for health insurance, posing a major threat to the space’s top players. Biden’s policy, on the other hand, supports the strengthening of the Affordable Care Act, which is ideal for the companies currently on the exchanges established …read more […]

Shareholders in Novavax, Inc. (NASDAQ:NVAX) may be thrilled to learn that the analysts have just delivered a major… …read more […]

The economic downturn since the coronavirus pandemic has been odd in so many ways. Why shouldn’t it expose some economic myths and misconceptions? …read more […]

There’s been a notable change in appetite for Netflix, Inc. (NASDAQ:NFLX) shares in the week since its second-quarter… …read more […]